Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02953353 · ClinicalTrials.gov registry record · NA
Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity
A NA study of Obesity, sponsored by University of Sao Paulo.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 3
- Study locations
NCT02953353: Completed NA study of Obesity, sponsored by University of Sao Paulo.
NCT02953353 is a NA study of Obesity that has completed, run by University of Sao Paulo. The registered enrollment target is 38 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02953353, a NA study of Obesity, has completed, sponsored by University of Sao Paulo.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overall goal of this proposal is to evaluate the efficacy of transcranial direct current stimulation (tDCS), a noninvasive neuromodulation technique, to facilitate weight loss and weight loss maintenance in obesity. This is a novel clinical research study that examines the therapeutic potential of an innovative biomedical treatment for weight loss.
Primary Outcome
The primary outcome will be change in body weight after two weeks intervention (tDCS alone) versus baseline (day 1), the change in body weight between the beginning and the end of the inpatient period (tDCS plus hypocaloric diet), and the change in body weight throughout follow-up (6 months), i.e. between the end of the tDCS intervention (end of the inpatient phase) and the end of the study.
Conditions Studied
Interventions
- DEVICE Active transcranial direct current stimulation (tDCS)
- OTHER Hypocaloric diet
- OTHER Sham transcranial direct current stimulation (tDCS)
Study Locations (3)
Massachusetts
- Human Nutrition Research Center on Aging, Tufts University - Boston
- Beth Israel Deaconess Medical Center, Harvard Medical School - Boston
São Paulo
- Clinical Hospital of Ribeirão Preto - Ribeirão Preto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2017-06-12 |
| Est. Completion | 2019-03-29 |
| Phase | NA |
What the finished NCT02953353 record still lists
NCT02953353 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Active transcranial direct current stimulation (tDCS) is the first listed.
NCT02953353 reports a single indexed study location in Massachusetts, São Paulo.
Frequently Asked Questions
What is clinical trial NCT02953353 about?
NCT02953353 is a clinical study titled "Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity". The overall goal of this proposal is to evaluate the efficacy of transcranial direct current stimulation (tDCS), a noninvasive neuromodulation technique, to facilitate weight loss and weight loss maintenance in obesity. This is a novel clinical research study that examines the therapeutic potential ...
What is the current status of trial NCT02953353?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2017-06-12. Estimated completion is 2019-03-29.
What conditions does trial NCT02953353 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT02953353?
The interventions under investigation include: Active transcranial direct current stimulation (tDCS) (DEVICE), Hypocaloric diet (OTHER), Sham transcranial direct current stimulation (tDCS) (OTHER).
Who is sponsoring clinical trial NCT02953353?
This trial is sponsored by University of Sao Paulo, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02953353 being conducted?
This trial has 3 study locations across Massachusetts, São Paulo. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02953353's enrollment target sits among peer trials
38 811th of 1053 higher than 239 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI